Fibralign is hosting the inaugural Lymphedema Summit on January 23-
Fibralign's first product, the BioBridge® Collagen Matrix has received 510(k) clearance from the FDA on January 07, 2016 for use in soft tissue support/repair (K151083). Click to view. BioBridge is a sterile thread-like surgical mesh designed for use in surgery to...
Michael Paukshto, PhD, CTO and co-founder of Fibralign Corporation, was awarded the 2014 Best New Investigator Award at the 11th Biennial NLN International Conference. Fibralign has developed and established an end-to-end manufacturing system for production of its...
Fibralign won the prestigious Medtech Innovator award at the 2014 WSGRC Medical Device Conference, placing first out of over 300 startups for this top honor and $125,000 prize.